BMJ Best Practice
最后审核时间: 十月 2018
最近更新时间: 一月 2018

小结

定义

病史和查体

关键诊断因素

  • 存在的危险因素
  • 奶类、蛋类、坚果、鱼类、甲壳类动物、小麦或大豆的摄取
  • 可重现的症状
  • 潮红、荨麻疹或皮肤的血管性水肿

其他诊断因素

  • 心动过速或心动过缓
  • 心动过速或心动过缓
  • 运动或劳累使病情恶化
  • 在反应前摄入酒精或药品

危险因素

  • 食物过敏家族史
  • 特应性皮炎
  • 新生儿
  • 围产期花生油暴露

诊断性检查

首要检查

  • 体外IgE特异性的免疫测定法
  • 皮肤点刺试验
全部具体信息

新兴检查

  • 特应性斑贴试验
  • 成分分辨诊断试验
全部具体信息

治疗流程

贡献者

A. Wesley Burks MD

Curnen Distinguished Professor and Chair

Department of Pediatrics

University of North Carolina

Chapel Hill

NC

利益冲突披露
AWB is an author of a number of references cited in this monograph. AWB has received grant funding from the NIH and FAAN, and he is a board member of FARE, NIH AITC Review Panel, NIH HAI Study Section, and World Allergy Organization; and he is a consultant for Adept Field Solutions, Aimmune Therapeutics, Inc., Dow AgroSciences, Inc., Genetech, GLG Research, Inc., Insys Therapeutics, Merck, Regeneron Pharmaceuticals, Inc., SRA International, Stallergenes, Sanofi US Services, and Valeant Pharmaceuticals North America, LLC. AWB is an independent contractor for PPD Development, LP; he has received a royalty payment from the American Society for Microbiology; and he is a minor stockholder for Allertein.

Assistant Professor

Department of Pediatrics

Division of Allergy and Immunology

University of Texas Southwestern Medical Center

Dallas

TX

利益冲突披露
JAB is on the speaker's bureau for Nutricia North America, Aimmune Therapeutics, Abbott Nutrition, and DBV Technologies and he sits on the advisory board for Aimmune Therapeutics and Food Allergy Research and Education. He has received consulting fees from Wedbush Securities and Aimmune Therapeutics, and he has received research funding from Aimmune Therapeutics, DBV Technologies, Nestle Health Sciences, the Foundation of the American College of Allergy, Asthma and Immunology, and Food Allergy Research and Education.

同行评议专家 查看所有

Assistant Professor of Pediatric Allergy and Immunology

Mount Sinai School of Medicine

New York

NY

利益冲突披露
JS declares that he has no competing interests.

Professor of Pediatrics

Mount Sinai School of Medicine

New York

NY

利益冲突披露
HAS holds a 4% interest in a biotech company, Allertein Pharmaceuticals LLC, which is developing an engineered recombinant protein vaccine for peanut allergy, and 45% interest in a virtual company, Herbal Springs LLC, that holds a patent application on an herbal product for treating asthma and another for treating food allergy. HAS is an author of a number of references cited in this monograph.

Consultant and Honorary Senior Lecturer in Paediatric Allergy

Evelina Children's Hospital

Guy's & St Thomas' Hospitals NHS Foundation Trust

London

UK

利益冲突披露
AF declares that he has no competing interests.

使用此内容应接受我们的免责声明